Integrated bulk-single-cell transcriptomics identifies IL17RB as a candidate prognostic marker in colon cancer.

Babalola DO, Sun X, Deng P, Jin S

DOI: 10.1007/s40203-026-00746-w
Published: 2026
Container: In silico pharmacology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s40203-026-00746-w,
  title = {Integrated bulk-single-cell transcriptomics identifies IL17RB as a candidate prognostic marker in colon cancer.},
  author = {Babalola DO and Sun X and Deng P and Jin S},
  year = {2026},
  journal = {In silico pharmacology},
  doi = {10.1007/s40203-026-00746-w},
  url = {https://doi.org/10.1007/s40203-026-00746-w}
}

RIS

TY  - JOUR
TI  - Integrated bulk-single-cell transcriptomics identifies IL17RB as a candidate prognostic marker in colon cancer.
AU  - Babalola DO
AU  - Sun X
AU  - Deng P
AU  - Jin S
PY  - 2026
JO  - In silico pharmacology
DO  - 10.1007/s40203-026-00746-w
UR  - https://doi.org/10.1007/s40203-026-00746-w
ER  -

APA

DO, B., X, S., P, D., & S, J. (2026). Integrated bulk-single-cell transcriptomics identifies IL17RB as a candidate prognostic marker in colon cancer.. In silico pharmacology. https://doi.org/10.1007/s40203-026-00746-w

Source records

pubmed · retrieved 2026-09-26T17:57:11.048Z